Search Results - Hyounggyoon Yoo
- Showing 1 - 8 results of 8
-
1
Drug-Drug Interactions between Tamsulosin and Mirabegron in Healthy Individuals Do Not Affect Pharmacokinetics and Hemodynamic Parameters Significantly by Wonsuk Shin, A-Young Yang, Hyounggyoon Yoo, Anhye Kim
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Assessing the Clinical Efficacy of Therapeutic Drug Monitoring for Risperidone and Paliperidone in Patients with Schizophrenia: Insights from a Clinical Data Warehouse by Wonsuk Shin, Dong Hyeon Lee, Hyounggyoon Yoo, Huiyoung Jung, Minji Bang, Anhye Kim
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
A Comparative Pharmacokinetic Study of Fexuprazan 10 mg: Demonstrating Bioequivalence with the Reference Formulation and Evaluating Steady State by Wonsuk Shin, A-Young Yang, Hyung Park, Hyejung Lee, Hyounggyoon Yoo, Anhye Kim
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Current Bioequivalence Study Designs in South Korea: A Comprehensive Analysis of Bioequivalence Study Reports Between 2013 and 2019 by Ki Young Huh, Eunwoo Kim, Soyoung Lee, Hyounggyoon Yoo, Seonghae Yoon, Kyung-Sang Yu, Jae-Yong Chung
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
YH12852, a Potent and Selective Receptor Agonist of 5‐hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional Constipation by Hyun A. Lee, Seol Ju Moon, Hyounggyoon Yoo, Mi Kyung Kim, Seong Bok Jang, Seoungoh Lee, Sohee Kim, Howard Lee
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Safety, Tolerability, and Serum/Tear Pharmacokinetics of Human Recombinant Epidermal Growth Factor Eyedrops in Healthy Subjects by Hyounggyoon Yoo, Seonghae Yoon, In-Jin Jang, Kyung-Sang Yu, Joon Young Hyon, Jungi Hwang, Inyoung Hwang, Jung Sunwoo, Jae-Yong Chung
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Safety, tolerability, pharmacokinetic, and pharmacodynamic characteristics of vutiglabridin: A first‐in‐class, first‐in‐human study by Joo Young Na, Deok Yong Yoon, Hyounggyoon Yoo, SeungHwan Lee, Kyung‐Sang Yu, In‐Jin Jang, Sang‐Ku Yoo, Youngah Kim, Jaeseong Oh
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
No drug-drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants by Wonsuk Shin, Min Young Park, Jongwoo Kim, Jihyeon Kim, Jun Hee Nam, Jongwon Choi, A‐Young Yang, Hyounggyoon Yoo, Yil‐Seob Lee, Anhye Kim
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book